Edwards Lifesciences stock falls as sales disappoint


Edwards Lifesciences Corp. lost more than a fifth of its market value as it turned in the biggest decline on the S&P 500. The company, which makes a less-invasive heart valve, generated an estimated $448 million in sales during the latest quarter, less than the $465 million to $485 million that was estimated in July, the company said.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of